Clinical and economic consequences of using dabigatran or rivaroxaban in patients with non-valvular atrial fibrillation Luís Silva Miguel, Jorge Ferreira

Medication adherence to direct anticoagulants in patients with non-valvular atrial fibrillation – A real world analysis Catarina Brízido, António Miguel Ferreira, Pedro Lopes, Christopher Strong, Gustavo Sá Mendes, Francisco Fernandes Gama, Anaí Durazzo, Gustavo Rocha Rodrigues, Daniel Matos, Sara Guerreiro, Sérgio Madeira, Jorge Ferreira, Pedro Adragão, Miguel Mendes

Economic evaluation of dabigatran for stroke prevention in patients with non-valvular atrial fibrillation Luís Silva Miguel, Evangelista Rocha, Jorge Ferreira